IN2012DN00624A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN00624A IN2012DN00624A IN624DEN2012A IN2012DN00624A IN 2012DN00624 A IN2012DN00624 A IN 2012DN00624A IN 624DEN2012 A IN624DEN2012 A IN 624DEN2012A IN 2012DN00624 A IN2012DN00624 A IN 2012DN00624A
- Authority
- IN
- India
- Prior art keywords
- fatigue
- treatments
- diseases
- prevention
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
- A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
Abstract
The present invention relates to the compounds and compositions of the invention and use thereof for treatment and/or prevention of fatigue, including fatigue associated with diseases or treatments. Figure 1A
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21908209P | 2009-06-22 | 2009-06-22 | |
PCT/US2010/039313 WO2011005473A2 (en) | 2009-06-22 | 2010-06-21 | Methods for treating or preventing fatigue |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN00624A true IN2012DN00624A (en) | 2015-06-12 |
Family
ID=43429751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN624DEN2012 IN2012DN00624A (en) | 2009-06-22 | 2010-06-21 |
Country Status (13)
Country | Link |
---|---|
US (5) | US8741950B2 (en) |
EP (1) | EP2445490B1 (en) |
JP (3) | JP6095366B2 (en) |
KR (3) | KR102173587B1 (en) |
CN (2) | CN106727486A (en) |
AU (1) | AU2010270971B2 (en) |
BR (1) | BRPI1015233A2 (en) |
CA (1) | CA2765463C (en) |
IN (1) | IN2012DN00624A (en) |
MX (1) | MX2012000034A (en) |
RU (1) | RU2567801C2 (en) |
TW (1) | TWI453014B (en) |
WO (1) | WO2011005473A2 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101335941B1 (en) | 2005-06-08 | 2013-12-04 | 에스케이바이오팜 주식회사 | Treatment of sleep-wake disorders |
JP6095366B2 (en) | 2009-06-22 | 2017-03-15 | エスケー バイオファーマシューティカルズ カンパニー リミテッド | Methods for treating or preventing fatigue |
WO2011055965A2 (en) | 2009-11-06 | 2011-05-12 | Sk Holdings Co., Ltd. | Methods for treating attention-deficit/hyperactivity disorder |
ES2743153T3 (en) * | 2009-11-06 | 2020-02-18 | Sk Biopharmaceuticals Co Ltd | Methods to treat fibromyalgia syndrome |
US8623913B2 (en) | 2010-06-30 | 2014-01-07 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating restless legs syndrome |
US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
CA2853779C (en) | 2011-12-21 | 2016-04-26 | Innobioscience, Llc | Combined therapy with interferon and andrographolides for multiple sclerosis |
AU2014248849B2 (en) * | 2013-03-13 | 2018-08-30 | Jazz Pharmaceuticals Ireland Limited | Treatment of cataplexy |
JP2016530240A (en) * | 2013-07-12 | 2016-09-29 | ジャズ ファーマスティカルズ インターナショナル スリー リミテッドJazz Pharmaceuticals International Iii Limited | Promotion of smoking cessation |
CA2917702A1 (en) | 2013-07-18 | 2015-01-22 | Jazz Pharmaceuticals International Iii Limited | Treatment for obesity |
KR102344748B1 (en) * | 2013-11-08 | 2021-12-30 | 레거시 헬스케어 (스위스) 에스에이 | Method for the management of cancer and treatment of cancer comorbidities |
TWI655179B (en) | 2014-02-28 | 2019-04-01 | 南韓商愛思開生物製藥股份有限公司 | Aminocarbonyl carbamate compound |
US10888542B2 (en) | 2014-02-28 | 2021-01-12 | Sk Biopharmaceuticals Co., Ltd. | Aminocarbonylcarbamate compounds |
US10195151B2 (en) | 2016-09-06 | 2019-02-05 | Jazz Pharmaceuticals International Iii Limited | Formulations of (R)-2-amino-3-phenylpropyl carbamate |
KR102513800B1 (en) | 2016-09-06 | 2023-03-24 | 에스케이바이오팜 주식회사 | Solvate form of (R)-2-amino-3-phenylpropyl carbamate |
EP4316592A2 (en) | 2016-10-06 | 2024-02-07 | Axsome Malta Ltd. | Carbamoyl phenylalaninol compounds and uses thereof |
MX2019014409A (en) | 2017-06-02 | 2022-03-17 | Jazz Pharmaceuticals Ireland Ltd | Methods and compositions for treating excessive sleepiness. |
KR102643275B1 (en) | 2017-07-31 | 2024-03-04 | 재즈 파마슈티칼즈 아일랜드 리미티드 | Carbamoyl phenylalaninol analogues and uses thereof |
JP7428480B2 (en) * | 2019-06-06 | 2024-02-06 | 雪印メグミルク株式会社 | Compositions for improving sleep and foods, medicines, and feed containing the compositions |
US10940133B1 (en) | 2020-03-19 | 2021-03-09 | Jazz Pharmaceuticals Ireland Limited | Methods of providing solriamfetol therapy to subjects with impaired renal function |
KR102390194B1 (en) * | 2020-08-03 | 2022-04-25 | 셀라이온바이오메드 주식회사 | A composition for treating Kca3.1 channel mediated diseases comprising phenylalkyl carbamate compounds |
WO2023091921A1 (en) * | 2021-11-16 | 2023-05-25 | Axsome Malta Ltd. | Methods and compositions for treating cognitive impairment |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL109872A (en) | 1993-06-10 | 2000-12-06 | Lilly Co Eli | Tetrahydrobenz ¬CD¾ indole-6-carboxamides for use in preventing emesis and pharmaceutical compositions comprising same |
KR100197892B1 (en) | 1994-09-09 | 1999-06-15 | 남창우 | Novel phenylalkylaminoalcohol carbamates and process for preparing the same |
KR0173862B1 (en) | 1995-02-11 | 1999-04-01 | 조규향 | O-carbamoyl- (D) -phenylalaninol compounds and their pharmaceutically useful salts and methods for their preparation |
US5756817C1 (en) | 1995-02-11 | 2001-04-17 | Sk Corp | O-carbamoyl-phenylananinol compounds their pharmaceutically useful salts and process for preparing the same |
KR0173863B1 (en) * | 1995-04-10 | 1999-04-01 | 조규향 | O-carbamoyl-phenylalanineol compounds having substituents on phenyl, pharmaceutically useful salts thereof, and preparation methods thereof |
WO1998015626A2 (en) | 1996-10-08 | 1998-04-16 | Institute Of Child Health | Mutant ciita molecule and uses thereof |
JP4068154B2 (en) * | 1996-10-10 | 2008-03-26 | エス ケー コーポレイション | O-carbamoyl-phenylalaninol compound, pharmaceutically useful salt thereof, and production method thereof |
WO1998017636A1 (en) | 1996-10-22 | 1998-04-30 | Ortho Pharmaceutical Corporation | Phenylalaninol derivatives for the treatment of central nervous system disorders |
US20040229951A1 (en) | 2003-05-15 | 2004-11-18 | Arthur Vanmoor | Method of treating fatigue by enhancing the effectiveness of the human immune system |
RU2267319C2 (en) * | 2003-07-15 | 2006-01-10 | Общество с ограниченной ответственностью "Интер-Кэр" | Pharmaceutical composition and method for treating chronic fatigue syndrome due to its application |
US20050080268A1 (en) | 2003-10-08 | 2005-04-14 | Yong-Moon Choi | Process of preparing O-carbamoyl compounds in the presence of active amine group |
KR20070083826A (en) * | 2004-10-28 | 2007-08-24 | 에스케이 주식회사 | Adjunctive therapy for depression |
KR101335941B1 (en) * | 2005-06-08 | 2013-12-04 | 에스케이바이오팜 주식회사 | Treatment of sleep-wake disorders |
US8552060B2 (en) | 2005-06-22 | 2013-10-08 | Sk Biopharmaceuticals Co., Ltd. | Methods for treatment of sexual dysfunction |
EP1928451B1 (en) | 2005-07-26 | 2011-12-28 | SK Biopharmaceuticals Co., LTD | Methods for treating substance-related disorders |
JP2010506845A (en) | 2006-10-13 | 2010-03-04 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Phenylalkylaminocarbamate composition |
JP6095366B2 (en) * | 2009-06-22 | 2017-03-15 | エスケー バイオファーマシューティカルズ カンパニー リミテッド | Methods for treating or preventing fatigue |
US8232315B2 (en) | 2009-06-26 | 2012-07-31 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating drug addiction and improving addiction-related behavior |
ES2743153T3 (en) | 2009-11-06 | 2020-02-18 | Sk Biopharmaceuticals Co Ltd | Methods to treat fibromyalgia syndrome |
WO2011055965A2 (en) | 2009-11-06 | 2011-05-12 | Sk Holdings Co., Ltd. | Methods for treating attention-deficit/hyperactivity disorder |
US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
US8623913B2 (en) | 2010-06-30 | 2014-01-07 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating restless legs syndrome |
AU2014248849B2 (en) * | 2013-03-13 | 2018-08-30 | Jazz Pharmaceuticals Ireland Limited | Treatment of cataplexy |
JP6215740B2 (en) * | 2014-03-14 | 2017-10-18 | 本田技研工業株式会社 | Part fastening structure |
-
2010
- 2010-06-21 JP JP2012517622A patent/JP6095366B2/en active Active
- 2010-06-21 KR KR1020197026173A patent/KR102173587B1/en active IP Right Grant
- 2010-06-21 CA CA2765463A patent/CA2765463C/en not_active Expired - Fee Related
- 2010-06-21 BR BRPI1015233A patent/BRPI1015233A2/en not_active Application Discontinuation
- 2010-06-21 CN CN201710080968.3A patent/CN106727486A/en active Pending
- 2010-06-21 US US13/379,793 patent/US8741950B2/en active Active
- 2010-06-21 MX MX2012000034A patent/MX2012000034A/en active IP Right Grant
- 2010-06-21 KR KR1020177020249A patent/KR102021075B1/en active IP Right Grant
- 2010-06-21 RU RU2012101947/15A patent/RU2567801C2/en active
- 2010-06-21 KR KR1020127001795A patent/KR20120098578A/en active Application Filing
- 2010-06-21 EP EP10797541.9A patent/EP2445490B1/en active Active
- 2010-06-21 WO PCT/US2010/039313 patent/WO2011005473A2/en active Application Filing
- 2010-06-21 IN IN624DEN2012 patent/IN2012DN00624A/en unknown
- 2010-06-21 AU AU2010270971A patent/AU2010270971B2/en active Active
- 2010-06-21 CN CN2010800277527A patent/CN102481274A/en active Pending
- 2010-06-22 TW TW099120382A patent/TWI453014B/en active
-
2014
- 2014-05-07 US US14/271,503 patent/US9464041B2/en active Active
-
2015
- 2015-07-03 JP JP2015134556A patent/JP6368285B2/en active Active
-
2016
- 2016-09-16 US US15/268,060 patent/US9999609B2/en active Active
-
2018
- 2018-05-18 US US15/983,944 patent/US10507192B2/en active Active
- 2018-07-05 JP JP2018128318A patent/JP2018188450A/en active Pending
-
2019
- 2019-10-31 US US16/670,382 patent/US20200061017A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN00624A (en) | ||
IN2012DN03883A (en) | ||
MX351464B (en) | Methods for the treatment of allergic diseases. | |
EP2493464A4 (en) | Methylsulfonylmethane (msm) for treatment of drug resistant microorganisms | |
MX2018009945A (en) | Novel compositions and methods for the treatment of immune related diseases. | |
MY173616A (en) | Compositions and methods for lowering triglycerides | |
UA108198C2 (en) | Substituted 2-acetamido-5-aryl-l, 2,4-triazolones and their use | |
NZ727304A (en) | Compositions and methods of use of phorbol esters for the treatment of stroke | |
EP2294184A4 (en) | Treatment of eye diseases and excessive neovascularization using a combined therapy | |
MX2011007930A (en) | Crystalline insulin-conjugates. | |
ZA201304638B (en) | Composition for use in the prevention and /or treatment of skin condition and skin diseases. | |
AU2011338383A8 (en) | Treatment of HER2-positive cancer with paclitaxel and trastuzumab-MCC-DM1 | |
MY161495A (en) | Virus like particle compositions and methods of use | |
IN2012DN02081A (en) | ||
MX343135B (en) | Fumagillol type compounds and methods of making and using same. | |
TN2011000482A1 (en) | Organic compounds and their uses | |
MX2009009761A (en) | Compositions and kits for treating influenza. | |
EA201001639A1 (en) | COMPOSITIONS AND METHODS FOR THEIR PRODUCTION AND APPLICATION | |
IN2012DN02471A (en) | ||
TNSN08400A1 (en) | Organic compounds and their uses | |
MY178905A (en) | Prevention, treatment and diagnosis of p.gingivalis infection | |
UA107204C2 (en) | ANTI-FUNCTIONAL COMPOSITION CONTAINING THE PYTHIUM OLIGANDRUM Fungal Organism | |
MX2009013353A (en) | Telomerase activating compounds and methods of use thereof. | |
WO2013098416A3 (en) | Pain relief compounds | |
MX342947B (en) | Treatment of type 2 diabetes. |